肥胖患者的体重适应性替扎肝素治疗。 - Suppr | 超能文献

Body weight adapted tinzaparin treatment in patients with obesity.

作者信息

Pfrepper Christian, Metze Michael, Weise Maria, Koch Elisabeth, Siegemund Roland, Siegemund Annelie, Petros Sirak

机构信息

Division of Hemostaseology, University Hospital Leipzig, Leipzig, Germany.

Department of Cardiology, University Hospital Leipzig, Leipzig, Germany.

出版信息

Thromb Res. 2022 Jun;214:65-67. doi: 10.1016/j.thromres.2022.04.011. Epub 2022 Apr 20.

DOI:10.1016/j.thromres.2022.04.011

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Body weight adapted tinzaparin treatment in patients with obesity.肥胖患者的体重适应性替扎肝素治疗。

Thromb Res. 2022 Jun;214:65-67. doi: 10.1016/j.thromres.2022.04.011. Epub 2022 Apr 20.

2

Tinzaparin in the treatment of venous thromboembolism.亭扎肝素治疗静脉血栓栓塞症

Expert Opin Pharmacother. 2003 Dec;4(12):2355-62. doi: 10.1517/14656566.4.12.2355.

3

The low molecular weight heparin, tinzaparin, in thrombosis and beyond.低分子量肝素——替扎肝素在血栓形成及其他方面的应用

Cardiovasc Drug Rev. 2002 Fall;20(3):199-216. doi: 10.1111/j.1527-3466.2002.tb00087.x.

4

Development of tinzaparin: a heparinase-digested low-molecular-weight heparin.替扎肝素的研发：一种经肝素酶消化的低分子量肝素。

Semin Thromb Hemost. 2000;26 Suppl 1:23-9. doi: 10.1055/s-2000-9246.

5

Treatment of venous thromboembolism with tinzaparin in oncological patients.在肿瘤患者中用亭扎肝素治疗静脉血栓栓塞症。

Minerva Med. 2019 Jun;110(3):251-258. doi: 10.23736/S0026-4806.19.06026-9.

6

Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.替扎肝素用于患有肺栓塞或深静脉血栓形成的门诊患者。

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1182-7. doi: 10.1345/aph.1E677. Epub 2005 Jun 14.

7

Selecting an agent for prophylaxis of venous thromboembolism.选择预防静脉血栓栓塞的药物。

Am J Health Syst Pharm. 2006 Dec 15;63(24):2448-50. doi: 10.2146/ajhp060231.

8

Optimizing antiplatelet and anticoagulant agents in the perioperative orthopedic surgery patient.

Orthopedics. 2005 May;28(5):453-8. doi: 10.3928/0147-7447-20050501-10.

9

Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.

Drugs. 1994 Oct;48(4):638-60. doi: 10.2165/00003495-199448040-00010.

10

Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.接受低分子量肝素、依诺肝素或替扎肝素以预防髋关节置换术后深静脉血栓形成的患者中血栓形成和出血的发生情况、与抗Xa、抗IIa活性及D - 二聚体血浆水平的关系。

Br J Haematol. 1999 Feb;104(2):230-40. doi: 10.1046/j.1365-2141.1999.01153.x.

引用本文的文献

1

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients.肥胖内科患者预防血栓形成时替扎肝素的体重调整剂量给药。

Res Pract Thromb Haemost. 2023 Jan 20;7(2):100054. doi: 10.1016/j.rpth.2023.100054. eCollection 2023 Feb.